Mouse models for thin filament disease

Advances in Experimental Medicine and Biology

Volumn 642, Issue , 2008, Pages 66-77

  Nguyen, Mai Anh T ^a   Hardeman, Edna C ^a,b,c  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCLE PROTEIN;

ANIMAL; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; MOUSE; MUSCLE DISEASE; MUTATION; PATHOLOGY; REVIEW; SKELETAL MUSCLE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCULAR DISEASES; MUTATION;

EID: 60549114494     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-84847-1_6     Document Type: Article

References (68)

1. Nowak KJ, Wattanasirichaigoon D, Goebel HH et al. Mutations in the skeletal alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet 1999; 23(2):208-212. (Pubitemid 29455395)
2. Wallefeld W, Krause S, Nowak KJ et al. Severe nemaline myopathy caused by mutations of the stop codon of skeletal muscle alpha actin gene (ACTA1). Neuromuscul Disord 2006; 16:541-547. (Pubitemid 44389820)
3. DAmico A, Graziano C, Pacileo G et al. Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation. Neuromuscul Disord 2006; 16:548-552. (Pubitemid 44374322)
4. Nowak KJ, Sewry CA, Navarro C et al. Nemaline myopathy caused by absence of alpha-skeletal muscle actin. Ann Neurol 2007; 61(2):175-184. (Pubitemid 46363844)
5. Laing NG, Wilton SD, Akkari PA et al. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet 1995; 9:75-79.
6. Tan P, Briner J, Boltshauser E et al. Homozygosity for the nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy. Neuromuscul Disord 1999; 9(8):573-579. (Pubitemid 29525541)
7. Donner K, Ollikainen M, Ridanpaa M et al. Mutations in the beta-tropomyosin (TPM2) gene-a rare cause of nemaline myopathy. Neuromuscul Disord 2002; 12:151-158. (Pubitemid 33152733)
8. Johnston JJ, Kelley RI, Crawford TO et al. A novel in the Amish caused by mutation in troponin T1. Am J Hum Genet 2000; 67(4):814-821.
9. Pelin K, Hilpela P, Donner K et al. Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Nat Acad Sci USA 1999; 96:2305-2310. (Pubitemid 29117910)
10. Gurgel-Giannetti J, Bang ML, Reed U et al. Lack of the C-terminal domain of nebulin in a patient with nemaline myopathy. Muscle Nerve 2002; 25(5):747-752. (Pubitemid 34462617)
11. Agrawal PB, Greenleaf RS, Tomczak KK et al. Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2. Am J Hum Genet 2007; 80(1):162-167. (Pubitemid 46047659)
12. Lehtokari VL, Ceuterick-de Groote C, de Jonghe P et al. Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2. Neuromusc Disord 2007; 17(6):433-442.
13. Kaindl AM, Ruschendorf F, Krause S et al. Missense mutations of ACTA1 cause dominant congenital myopathy with cores. J Med Genet 2004; 41:842-848. (Pubitemid 39524311)
14. Laing NG, Clarke NF, Dye DE et al. Actin mutations are one cause of congenital fiber type disproportion. Ann Neurol 2004; 56:689-694. (Pubitemid 39540749)
15. Clarke NF, Ilkovski B, Cooper S et al. The pathologenesis of ACTA1-related congenital fiber type disproportion, Ann Neirol 2007; 61:552-561. (Pubitemid 47068137)
16. Bamshad M, Watkins WS, Zenger RK et al. A gene for distal arthrogryposis type I maps to the pericentrimeric region of chromosome 9. Am J Hum Genet 1994; 55:1153-1158. (Pubitemid 24355569)
17. Sung SS, Brassington AM, Grannatt K et al. Mutations in genes encoding fast-twitch contractile proteins cause distal arthrogryposis syndromes. Am J Hum Genet 2003; 72:681-690. (Pubitemid 36255966)
18. Sung SS, Brassington AM, Krakowiak PA et al. Mutations in TNNT3 cause multiple congenital contractures: A second locus for distal arthogryposis type 2B. Am J Hum Genet 2003; 73:212-214. (Pubitemid 36793793)
19. Wallgren-Pettersson C, Lehtokari VL, Kalimo H et al. Distal myopathy caused by homozygous missense mutations in the nebulin gene. Brain 2007; 130:1465-1476. (Pubitemid 47355931)
20. Mogensen J, Klausen IC, Pedersen AK et al. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest 1999; 103:R39-R43. (Pubitemid 29535504)
21. Olson et al. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 2001; 33:723-732. (Pubitemid 32538985)
22. Kimura A, Harada H, Park JE et al. Mutation in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 2001; 16(4):379-382.
23. Drera B, Zoppi N, Barlati et al. Recurrence of the p.R156X TNNI2 mutation in distal arthrogryposis type 2B. Clin Genet 2006; 70(6):532-534. (Pubitemid 44741477)
24. Davis J, Wen H, Edwards T et al. Thin filament disinhibition by restrictive cardiomyopathy mutatnt R193 troponin I induces Ca2-independent mechanical tone and acute myocyte remodeling. Cir Res 2007; 100(10):1494-1502. (Pubitemid 46834762)
25. Chang AN, Potter JD. Sarcomeric protein mutations in dilated cardiomyopathy. Heart Fail Rev 2005; 10:225-235. (Pubitemid 43115832)
26. Thierfelder L, Watkins H, MacRae C et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 1994; 77:701-712.
27. Venkatraman G, Harada K, Gomes AV et al. Different functional properties of troponin T mutants that cause dilated cardiomyopathy. J Biol Chem 2003; 278(43):41670-41676. (Pubitemid 37310424)
28. Harada K, Morimoto S. Inherited cardiomyopathies as a troponin disease. Jpn J Physiol 2004; 54:307-318.
29. Lammens M, Moerman P, Fryns JP et al. Fetal alkinesia sequence caused by nemaline myopathy. Neuropediatrics 1997; 28(2):116-119. (Pubitemid 27283054)
30. McComb RD, Markesbery WR, OConnor WN. Fatal neonatal nemaline myopathy with multiple congenital anomalies. J Pediatr 1979; 94(1):47-51. (Pubitemid 9036127)
31. Shahar E, Tervo RC, Murthy EG. Heterogeneity of nemaline myopathy. A follow up of 13 cases. Pediatr Neurosci 1988; 14(5):236-240. (Pubitemid 19232924)
32. Davies MJ, Ballantine S, Darracott S et al. Nemaline bodies in the heart: Anomalous Z bands with a periodic structure suggesting tropomyosin in human cardiac muscle biopsies. Cardiovasc Res 1973; 7(3):408-711.
33. Ishibashi-Ueda H, Imakita M, Yutani C et al. Congenital nemaline myopathy with dilated cardiomyopathy: An autopsy study. Hum Pathol 1990; 21:77-82. (Pubitemid 20042408)
34. Muller-Hocker J, Schafer S, Mendel B et al. Nemaline cardiomyopathy in a young adult: An ultraimmunohistochemical study and review of the literature. Ultrastruct Pathol 2000; 24:407-416. (Pubitemid 32060312)
35. Jockusch BM, Veldman H, Griffiths GW et al. Immunofluorescence microscopy of a myopathy. alpha-Actinin is a major constituent of nemaline rods. Exp Cell Res 1980; 127:409-420. (Pubitemid 10012226)
36. Yamaguchi M, Robson RM, Stromer MH et al. Actin filaments form the backbone of nemaline myopathy rods. Nature 1978; 271:265-267. (Pubitemid 8256552)
37. Schroder R, Reimann J, Salmikangas P et al. Beyond LGMD1A: Myotilin is a component of central core lesions and nemaline rods. Neuromuscul Disord 2003; 13:451-455. (Pubitemid 36939181)
38. Morris EP, Nneji G, Squire JM. The three-dimensional structure of the nemaline rod Z-band. J Cell Biol 1990; 111:2961-2978. (Pubitemid 120034035)
39. Volpe P, Damiani E, Margreth A et al. Fast to slow change of myosin in nemaline myopathy: Electrophoretic and immunologic evidence. Neurology 1982; 32(1):37-41. (Pubitemid 12205262)
40. Kinoshita M, Satoyoshi E. Type 1 fiber atrophy and nemaline bodies. Arch Neurol 1974; 31(6):423-425.
41. Shimomura C, Noaka I. Nemaline myopathy: Comparative muscle histochemistry in the severe neonatal, moderate congenital and adult-onset forms. Pediatr Neurol 1989; 5:25-31. (Pubitemid 19074477)
42. Wallgren-Pettersson C. Congenital nemaline myopathy. A clinical follow-up of twelve patients. J Neurol Sci 1989; 89:1-14. (Pubitemid 19029970)
43. Ilkovski B, Cooper ST, Nowak K et al. Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin gene. Am J Hum Genet 2001; 68(6):1333-1343. (Pubitemid 32510609)
44. Miike T, Ohtani Y, Tamari H et al. Muscle fiber type transformation in nemaline myopathy and congenital fiber type disproportion. Brain Dev 1986; 8(5):526-532. (Pubitemid 17204005)
45. Meredith C, Herrmann R, Parry C et al. Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause Laing early distal myopathy (MPD1). Am J Hum Genet 2004; 75:703-708. (Pubitemid 39244785)
46. Goebel HH. Cap disease uncapped. Neuromusc Disord 2007; 17:429-432. (Pubitemid 46783451)
47. Tajsharghi H, Ohlsson M, Linberg C et al. Congenital myopathy with nemaline rods and cap structures caused by a mutation in the β-tropomyosin gene (TPM2) 2007; 64(9):1334-1338.
48. Corbett MA, Robinson CS, Dunglison GF et al. A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy. Hum Mol Genet 2001; 10:317-328. (Pubitemid 32166543)
49. Joya JE, Kee AJ, Nair-Shalliker V et al. Muscle weakness in a mouse model of nemaline myopathy can be reversed with exercise and reveals a novel myofiber repair mechanism. Hum Mol Genet 2007; 13(21):2633-2645. (Pubitemid 39485412)
50. Sanoudou D, Corbett MA, Han M et al. Skeletal muscle repair in a mouse model of nemaline myopathy. Hum Mol Genet 2006; 15(17):2603-2612. (Pubitemid 44288689)
51. De Haan A, Van Der Viet MR, Gommans IMP et al. Skeletal muscle of mice with a mutation in slow α-tropomyosin is weaker at lower lengths. Neuromusc Dis 2002; 952-957. (Pubitemid 35408676)
52. Corbett MA, Akkari PA, Domazetovska A et al. An alpha-tropomyosin mutation alters dimer preference in nemaline myopathy. Ann Neurol 2004; 57(1):42-49.
53. Witt CC, Burkat C, Labeit D et al. Nebulin regulates thin filament length, contractility and Z-disk structure in vivo. EMBO J 2006; 25:3843-3855. (Pubitemid 44300270)
54. Bang ML, Li X, Littlefield R et al. Nebulin-deficient mice exhibit shorter thin filament lengths and reduced contractile function in skeletal muscle. J Cell Biol 2006; 173:905-916.
55. Gurgel-Gianneti J, Reed U, Bang ML et al. Nebulin expression in patient with nemaline myopathy. Neuromuscul Disord 2001; 11(2):154-162. (Pubitemid 32197518)
56. Crawford K, Flick R, Close L et al. Mice lacking skeletal muscle actin show reduced muscle strength and growth deficits and die during the neonatal period. Mol Cell Biol 2002; 22(16):5887-5896. (Pubitemid 34815837)
57. Muthuchamy M, Pieples K, Rethinasamy P et al. Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction. Circ Res 1999; 85:47-56. (Pubitemid 29321041)
58. Prabhakar R, Boivin GP, Grupp IL et al. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J Mol Cell Cardiol 2001; 33:1815-1828. (Pubitemid 32977135)
59. Rajan S, Ahmad RPH, Jagatheesan G et al. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity. Circ Research 2007; 101:205-214. (Pubitemid 47196588)
60. Tsoutsman T, Chung J, Doolan A et al. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 2006; 41(4):623-632. (Pubitemid 44374544)
61. James J, Zhang Y, Osinska H et al. Transgenic modelling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res 2000; 87(9):805-811.
62. Rogers MA, Evans WJ. Changes in skeletal muscle with aging:effects of exercise training. Exerc Sport Sci Rev 1993; 21:65-102.
63. Wanke T, Toifl K, Merkle et al. Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest 1994; 105(2):475-482. (Pubitemid 24066721)
64. Vignos PJ. Physical models of rehabilitation in neuromuscular disease. Musc Nerve 1983; 6(5):323-338.
65. Nair-Shalliker V, Kee AJ, Joya JE et al. Myofiber adaptational response to exercise in a mouse model of nemaline myopathy. Musc Nerve 2004; 30:470-480. (Pubitemid 39288151)
66. Dupler TL, Cortes C. Effects of whole-body resistance training regimen in the elderly. Gerontology 1993; 39(6):314-319. (Pubitemid 24024644)
67. Lindeman E, Spaans F, Reulen J et al. Progressive resistance training in neuromuscular patients. Effects on force and surface EMG. J Electromyogr Kinesiol 1999; 9(6):379-384. (Pubitemid 29505242)
68. Ryan MM, Sy C, Rudge S et al. Dietary L-Tyrosine supplementation in nemaline myopathy. J Child Neurol 2007; Ahead of print.